Menopausal hormone therapy and menopausal symptoms

Fertility and Sterility

Volumn 101, Issue 4, 2014, Pages 905-915

  Al Safi, Zain A ^a   Santoro, Nanette ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

hormone therapy; Menopause; vasomotor symptoms; vulvovaginal atrophy

Indexed keywords

BAZEDOXIFENE; CLONIDINE; ESCITALOPRAM; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FLUOXETINE; FOLLITROPIN; GABAPENTIN; GESTAGEN; INHIBIN B; MEDROXYPROGESTERONE ACETATE; OSPEMIFENE; PAROXETINE; TISSUE SELECTIVE ESTROGEN COMPLEX; UNCLASSIFIED DRUG; VENLAFAXINE;

ABDOMINAL OBESITY; ACUPUNCTURE; BONE DENSITY; BONE TURNOVER; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLIMACTERIUM; COGNITIVE THERAPY; DEPRESSION; DYSPAREUNIA; EDUCATIONAL STATUS; ESTROGEN THERAPY; ETHNIC DIFFERENCE; FOLLOW UP; HEART PROTECTION; HORMONAL THERAPY; HOT FLUSH; HUMAN; LIFESTYLE MODIFICATION; MENOPAUSAL HORMONE THERAPY; MENOPAUSE; META ANALYSIS (TOPIC); NIGHT SWEAT; OSTEOLYSIS; OSTEOPOROSIS; PERIODIC LIMB MOVEMENT DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; RESTLESS LEGS SYNDROME; REVIEW; RISK BENEFIT ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SMOKING; SOCIAL STATUS; TREATMENT DURATION; VAGINA ATROPHY; VAGINAL DRYNESS; VASOMOTOR DISORDER; VENOUS THROMBOEMBOLISM;

HORMONE THERAPY; MENOPAUSE; VASOMOTOR SYMPTOMS; VULVOVAGINAL ATROPHY;

CAUSALITY; DEPRESSION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EVIDENCE-BASED MEDICINE; FEMALE; HOT FLASHES; HUMANS; INCIDENCE; MENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SLEEP DISORDERS; TREATMENT OUTCOME; VULVODYNIA; WOMEN'S HEALTH;

EID: 84897425144     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.02.032     Document Type: Review

References (109)

1. S.L. Murphy, J.Q. Xu, and K.D. Kochanek Deaths: final data for 2010. National Vital Statistics Reports. Vol. 61, No. 4 2013 National Center for Health Statistics Hyattsville, MD
2. National Center for Health Statistics Health, United States, 2012: with special feature on emergency care 2013 National Center for Health Statistics Hyattsville, MD
3. E.B. Gold, A. Colvin, N. Avis, J. Bromberger, G.A. Greendale, and L. Powell et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation Am J Public Health 96 2006 1226 1235
4. N. Santoro, and J. Komi Prevalence and impact of vaginal symptoms among postmenopausal women J Sex Med 6 2009 2133 2142
5. H.M. Kravitz, X. Zhao, J.T. Bromberger, E.B. Gold, M.H. Hall, and K.A. Matthews et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women Sleep 31 2008 979 990
6. J.T. Bromberger, L.L. Schott, H.M. Kravitz, M. Sowers, N.E. Avis, and E.B. Gold et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN) Arch Gen Psychiatry 67 2010 598 607
7. S.D. Harlow, M. Gass, J.E. Hall, R. Lobo, P. Maki, and R.W. Rebar et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging Fertil Steril 97 2012 843 851
8. F. Kronenberg Hot flashes: epidemiology and physiology Ann N Y Acad Sci 592 1990 52 86 discussion 123-33
9. R.R. Freedman, and T.A. Roehrs Lack of sleep disturbance from menopausal hot flashes Fertil Steril 82 2004 138 144
10. R.C. Thurston, J.T. Bromberger, H. Joffe, N.E. Avis, R. Hess, and C.J. Crandall et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 15 2008 841 847
11. R.C. Thurston, M.R. Sowers, K. Sutton-Tyrrell, S.A. Everson-Rose, T.T. Lewis, and D. Edmundowicz et al. Abdominal adiposity and hot flashes among midlife women Menopause 15 2008 429 434
12. R.C. Thurston, and H. Joffe Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation Obstet Gynecol Clin North Am 38 2011 489 501
13. E.W. Freeman, M.D. Sammel, H. Lin, C.R. Gracia, G.W. Pien, and D.B. Nelson et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women Obstet Gynecol 110 2007 230 240
14. R.R. Freedman, and W. Krell Reduced thermoregulatory null zone in postmenopausal women with hot flashes Am J Obstet Gynecol 181 1999 66 70
15. R.R. Freedman, and C.M. Blacker Estrogen raises the sweating threshold in postmenopausal women with hot flashes Fertil Steril 77 2002 487 490
16. C.J. Crandall, S.L. Crawford, and E.B. Gold Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors Am J Med 119 2006 S52 S60
17. J.M. Malacara, E.L. Perez-Luque, S. Martinez-Garza, and F.J. Sanchez-Marin The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women Maturitas 49 2004 163 169
18. T.R. Rebbeck, H.I. Su, M.D. Sammel, H. Lin, T.V. Tran, and C.R. Gracia et al. Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition Menopause 17 2010 1026 1034
19. N.F. Col, J.R. Guthrie, M. Politi, and L. Dennerstein Duration of vasomotor symptoms in middle-aged women: a longitudinal study Menopause 16 2009 453 457
20. E.W. Freeman, M.D. Sammel, H. Lin, Z. Liu, and C.R. Gracia Duration of menopausal hot flushes and associated risk factors Obstet Gynecol 117 2011 1095 1104
21. J.R. Guthrie, L. Dennerstein, J.R. Taffe, and V. Donnelly Health care-seeking for menopausal problems Climacteric 6 2003 112 117
22. R.C. Thurston, K. Sutton-Tyrrell, S.A. Everson-Rose, R. Hess, L.H. Powell, and K.A. Matthews Hot flashes and carotid intima media thickness among midlife women Menopause 18 2011 352 358
23. R.C. Thurston, K. Sutton-Tyrrell, S.A. Everson-Rose, R. Hess, and K.A. Matthews Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study Circulation 118 2008 1234 1240
24. C.J. Crandall, Y. Zheng, S.L. Crawford, R.C. Thurston, E.B. Gold, and J.M. Johnston et al. Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis Menopause 16 2009 239 246
25. C.J. Crandall, C.H. Tseng, S.L. Crawford, R.C. Thurston, E.B. Gold, and J.M. Johnston et al. Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition J Bone Miner Res 26 2011 840 849
26. J. Svartberg, D. von Muhlen, D. Kritz-Silverstein, and E. Barrett-Connor Vasomotor symptoms and mortality: the Rancho Bernardo Study Menopause 16 2009 888 891
27. J.P. Semmens, and G. Wagner Estrogen deprivation and vaginal function in postmenopausal women JAMA 248 1982 445 448
28. L. Pandit, and J.G. Ouslander Postmenopausal vaginal atrophy and atrophic vaginitis Am J Med Sci 314 1997 228 231
29. L.M. Pastore, R.A. Carter, B.S. Hulka, and E. Wells Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative Maturitas 49 2004 292 303
30. R. Green, A.J. Polotsky, R.P. Wildman, A.P. McGinn, J. Lin, and C. Derby et al. Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation Climacteric 13 2010 376 384
31. A. Mehta, and G. Bachmann Vulvovaginal complaints Clin Obstet Gynecol 51 2008 549 555
32. H.M. Kravitz, P.A. Ganz, J. Bromberger, L.H. Powell, K. Sutton-Tyrrell, and P.M. Meyer Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition Menopause 10 2003 19 28
33. D.J. Buysse, C.F. Reynolds 3rd, T.H. Monk, S.R. Berman, and D.J. Kupfer The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research Psychiatry Res 28 1989 193 213
34. M.H. Hall, K.A. Matthews, H.M. Kravitz, E.B. Gold, D.J. Buysse, and J.T. Bromberger et al. Race and financial strain are independent correlates of sleep in midlife women: the SWAN sleep study Sleep 32 2009 73 82
35. R.R. Freedman, and T.A. Roehrs Sleep disturbance in menopause Menopause 14 2007 826 829
36. R.R. Freedman, and T.A. Roehrs Effects of REM sleep and ambient temperature on hot flash-induced sleep disturbance Menopause 13 2006 576 583
37. H.M. Kravitz, and H. Joffe Sleep during the perimenopause: a SWAN story Obstet Gynecol Clin North Am 38 2011 567 586
38. M.H. Hall, M.L. Okun, M. Sowers, K.A. Matthews, H.M. Kravitz, and K. Hardin et al. Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN Sleep Study Sleep 35 2012 783 790
39. D.J. Buysse Insomnia JAMA 309 2013 706 716
40. E.W. Freeman, M.D. Sammel, J.A. Grisso, M. Battistini, B. Garcia-Espagna, and L. Hollander Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women J Womens Health Gend Based Med 10 2001 67 76
41. American College of Obstetricians and Gynecologists Management of menopausal symptoms. Practice Bulletin No. 141 Obstet Gynecol 123 2014 202 216
42. A. Daley, H. Stokes-Lampard, and C. Macarthur Exercise for vasomotor menopausal symptoms Cochrane Database Syst Rev 2011 CD006108
43. C.H. Kroenke, B.J. Caan, M.L. Stefanick, G. Anderson, R. Brzyski, and K.C. Johnson et al. Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative Menopause 19 2012 980 988
44. R.R. Freedman, and S. Woodward Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring Am J Obstet Gynecol 167 1992 436 439
45. G.R. Elkins, W.I. Fisher, A.K. Johnson, J.S. Carpenter, and T.Z. Keith Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial Menopause 20 2013 291 298
46. B. Ayers, M. Smith, J. Hellier, E. Mann, and M.S. Hunter Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial Menopause 19 2012 749 759
47. J.F. Carmody, S. Crawford, E. Salmoirago-Blotcher, K. Leung, L. Churchill, and N. Olendzki Mindfulness training for coping with hot flashes: results of a randomized trial Menopause 18 2011 611 620
48. M.S. Lee, B.C. Shin, and E. Ernst Acupuncture for treating menopausal hot flushes: a systematic review Climacteric 12 2009 16 25
49. K.M. Newton, S.D. Reed, K.A. Guthrie, K.J. Sherman, C. Booth-Laforce, and B. Caan et al. Efficacy of yoga for vasomotor symptoms: a randomized controlled trial Menopause 2013 Sep 16 [Epub ahead of print]
50. L.S. Cohen, H. Joffe, K.A. Guthrie, K.E. Ensrud, M. Freeman, and J.S. Carpenter et al. Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial Menopause 2014 Jan 27 [Epub ahead of print]
51. D.F. Archer, D.W. Sturdee, R. Baber, T.J. de Villiers, A. Pines, and R.R. Freedman et al. Menopausal hot flushes and night sweats: where are we now? Climacteric 14 2011 515 528
52. H.D. Nelson, K.K. Vesco, E. Haney, R. Fu, A. Nedrow, and J. Miller et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis JAMA 295 2006 2057 2071
53. V. Stearns, K.L. Beebe, M. Iyengar, and E. Dube Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial JAMA 289 2003 2827 2834
54. C.L. Loprinzi, J.A. Sloan, E.A. Perez, S.K. Quella, P.J. Stella, and J.A. Mailliard et al. Phase III evaluation of fluoxetine for treatment of hot flashes J Clin Oncol 20 2002 1578 1583
55. J.S. Carpenter, K.A. Guthrie, J.C. Larson, E.W. Freeman, H. Joffe, and S.D. Reed et al. Effect of escitalopram on hot flash interference: a randomized, controlled trial Fertil Steril 97 2012 1399 1404.e1
56. R. Battaglino, J. Fu, U. Spate, U. Ersoy, M. Joe, and L. Sedaghat et al. Serotonin regulates osteoclast differentiation through its transporter J Bone Miner Res 19 2004 1420 1431
57. M. Bliziotes, A. Eshleman, B. Burt-Pichat, X.W. Zhang, J. Hashimoto, and K. Wiren et al. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells Bone 39 2006 1313 1321
58. I. Westbroek, A. van der Plas, K.E. de Rooij, J. Klein-Nulend, and P.J. Nijweide Expression of serotonin receptors in bone J Biol Chem 276 2001 28961 28968
59. S.J. Diem, T.L. Blackwell, K.L. Stone, K. Yaffe, E.M. Haney, and M.M. Bliziotes et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures Arch Intern Med 167 2007 1240 1245
60. L. Spangler, D. Scholes, R.L. Brunner, J. Robbins, S.D. Reed, and K.M. Newton et al. Depressive symptoms, bone loss, and fractures in postmenopausal women J Gen Intern Med 23 2008 567 574
61. S.J. Diem, K. Ruppert, J.A. Cauley, Y. Lian, J.T. Bromberger, and J.S. Finkelstein et al. Rates of bone loss among women initiating antidepressant medication use in midlife J Clin Endocrinol Metab 98 2013 4355 4363
62. C.L. Loprinzi, J.W. Kugler, J.A. Sloan, J.A. Mailliard, B.I. LaVasseur, and D.L. Barton et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial Lancet 356 2000 2059 2063
63. K. Sideras, J.N. Ingle, M.M. Ames, C.L. Loprinzi, D.P. Mrazek, and J.L. Black et al. Coprescription of tamoxifen and medications that inhibit CYP2D6 J Clin Oncol 28 2010 2768 2776
64. V.S. Williams, D.S. Baldwin, S.L. Hogue, S.E. Fehnel, K.A. Hollis, and H.M. Edin Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey J Clin Psychiatry 67 2006 204 210
65. A.L. Montejo, G. Llorca, J.A. Izquierdo, and F. Rico-Villademoros Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction J Clin Psychiatry 62 Suppl 3 2001 10 21
66. V. Stearns, R. Slack, N. Greep, R. Henry-Tilman, M. Osborne, and C. Bunnell et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial J Clin Oncol 23 2005 6919 6930
67. R. Basson, and W.W. Schultz Sexual sequelae of general medical disorders Lancet 369 2007 409 424
68. S.H. Kennedy, S.E. Dickens, B.S. Eisfeld, and R.M. Bagby Sexual dysfunction before antidepressant therapy in major depression J Affect Disord 56 1999 201 208
69. E. Fooladi, R.J. Bell, and S.R. Davis Management strategies in SSRI-associated sexual dysfunction in women at midlife Climacteric 15 2012 306 316
70. M. Landen, E. Eriksson, H. Agren, and T. Fahlen Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors J Clin Psychopharmacol 19 1999 268 271
71. K. Brück, and E. Zeisberger Adaptive changes in thermoregulation and their neuropharmacological basis E. Schönbaum, P. Lomax, Thermoregulation, physiology and biochemistry 1990 Pergamopn New York 255 307
72. R.R. Freedman, and R. Dinsay Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women Fertil Steril 74 2000 20 23
73. K.J. Pandya, R.F. Raubertas, P.J. Flynn, H.E. Hynes, R.J. Rosenbluth, and J.J. Kirshner et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study Ann Intern Med 132 2000 788 793
74. T. Guttuso Jr., R. Kurlan, M.P. McDermott, and K. Kieburtz Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial Obstet Gynecol 101 2003 337 345
75. D.A. Butt, M. Lock, J.E. Lewis, S. Ross, and R. Moineddin Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial Menopause 15 2008 310 318
76. K.A. Toulis, T. Tzellos, D. Kouvelas, and D.G. Goulis Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis Clin Ther 31 2009 221 235
77. M. Saletu, P. Anderer, G.M. Saletu-Zyhlarz, S. Parapatics, G. Gruber, and S. Nia et al. Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome J Neural Transm 117 2010 463 473
78. J.V. Pinkerton, R. Kagan, D. Portman, R. Sathyanarayana, and M. Sweeney Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause Menopause 2013 Oct 28 [Epub ahead of print]
79. K.J. Pandya, G.R. Morrow, J.A. Roscoe, H. Zhao, J.T. Hickok, and E. Pajon et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial Lancet 366 2005 818 824
80. North American Menopause Society The 2012 hormone therapy position statement of: The North American Menopause Society Menopause 19 2012 257 271
81. National Institutes of Health National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms Ann Intern Med 142 2005 1003 1013
82. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
83. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, and H. Black et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
84. J.E. Manson, R.T. Chlebowski, M.L. Stefanick, A.K. Aragaki, J.E. Rossouw, and R.L. Prentice et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials JAMA 310 2013 1353 1368
85. H.D. Nelson, E. Haney, L. Humphrey, J. Miller, A. Nedrow, and C. Nicolaidis et al. Management of menopause-related symptoms Evid Rep Technol Assess (Summ) 2005 1 6
86. M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, and H. Levesque et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study Circulation 115 2007 840 845
87. J.E. Manson, J. Hsia, K.C. Johnson, J.E. Rossouw, A.R. Assaf, and N.L. Lasser et al. Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
88. J. Suckling, A. Lethaby, and R. Kennedy Local oestrogen for vaginal atrophy in postmenopausal women Cochrane Database Syst Rev 2006 CD001500
89. D.W. Sturdee, and N. Panay Recommendations for the management of postmenopausal vaginal atrophy Climacteric 13 2010 509 522
90. North American Menopause Society The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society Menopause 14 2007 355 371
91. D.J. Portman, G.A. Bachmann, and J.A. Simon Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy Menopause 20 2013 623 630
92. J. Komi, J. Heikkinen, E.M. Rutanen, K. Halonen, R. Lammintausta, and O. Ylikorkala Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women Gynecol Endocrinol 18 2004 152 158
93. G.T. Wurz, L.H. Soe, and M.W. Degregorio Ospemifene, vulvovaginal atrophy, and breast cancer Maturitas 74 2013 220 225
94. L. Udoff, P. Langenberg, and E.Y. Adashi Combined continuous hormone replacement therapy: a critical review Obstet Gynecol 86 1995 306 316
95. W. Somboonporn, S. Panna, T. Temtanakitpaisan, S. Kaewrudee, and S. Soontrapa Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis Menopause 18 2011 1060 1066
96. S. Furness, H. Roberts, J. Marjoribanks, A. Lethaby, M. Hickey, and C. Farquhar Hormone therapy in postmenopausal women and risk of endometrial hyperplasia Cochrane Database Syst Rev 2009 CD000402
97. A. Gadducci, N. Biglia, S. Cosio, P. Sismondi, and A.R. Genazzani Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue Gynecol Endocrinol 25 2009 807 815
98. G.D. Lowe, M.N. Upton, A. Rumley, A. McConnachie, D.S. O'Reilly, and G.C. Watt Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein-a cross-sectional population survey Thromb Haemost 86 2001 550 556
99. American College of Obstetricians and Gynecologists ACOG committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism Obstet Gynecol 121 2013 887 890
100. J.V. Pinkerton, L. Abraham, A.G. Bushmakin, J.C. Cappelleri, J. Racketa, and H. Shi et al. Evaluation of the efficacy and safety of bazedoxifene/ conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) Trials J Womens Health (Larchmt) 23 2014 18 28
101. B.S. Komm, Y.P. Kharode, P.V. Bodine, H.A. Harris, C.P. Miller, and C.R. Lyttle Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity Endocrinology 146 2005 3999 4008
102. J.V. Pinkerton, W.H. Utian, G.D. Constantine, S. Olivier, and J.H. Pickar Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial Menopause 16 2009 1116 1124
103. W. Utian, H. Yu, J. Bobula, S. Mirkin, S. Olivier, and J.H. Pickar Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women Maturitas 63 2009 329 335
104. R.T. Chlebowski, S.L. Hendrix, R.D. Langer, M.L. Stefanick, M. Gass, and D. Lane et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial JAMA 289 2003 3243 3253
105. R.T. Chlebowski, G.L. Anderson, M. Gass, D.S. Lane, A.K. Aragaki, and L.H. Kuller et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women JAMA 304 2010 1684 1692
106. J.K. Ockene, D.H. Barad, B.B. Cochrane, J.C. Larson, M. Gass, and S. Wassertheil-Smoller et al. Symptom experience after discontinuing use of estrogen plus progestin JAMA 294 2005 183 193
107. R.L. Brunner, A. Aragaki, V. Barnabei, B.B. Cochrane, M. Gass, and S. Hendrix et al. Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial Menopause 17 2010 946 954
108. G. Heiss, R. Wallace, G.L. Anderson, A. Aragaki, S.A. Beresford, and R. Brzyski et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin JAMA 299 2008 1036 1045
109. E.G. Lipov, J.R. Joshi, S. Sanders, K. Wilcox, S. Lipov, and H. Xie et al. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study Lancet Oncol 9 2008 523 532